Showing results (271-280 of 379) with videos related to
Sort By:
Pageof 38
Clinical Kidney Journal|September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.Journal of the American Society of Nephrology : JASN|July 12, 2019
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled TrialsLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.Journal of the American Society of Nephrology : JASN|May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesToshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.Lancet (London, England)|April 4, 2023
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trialHiddo J L Heerspink, Jai Radhakrishnan, Charles E Alpers, et al.Diabetes, Obesity & Metabolism|May 19, 2022
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysisChao Li, Jie Yu, Carinna Hockham, et al.Journal of the American Society of Nephrology : JASN|April 12, 2014
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyDick de Zeeuw, Blai Coll, Dennis Andress, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2026
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKDHiddo J L Heerspink, Clare Arnott, Jonathan Barratt, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 2, 2021
The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized TrialSimke W Waijer, Ron T Gansevoort, George L Bakris, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2016
The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysisSunil V Badve, Suetonia C Palmer, Giovanni F M Strippoli, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 8, 2021
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney DiseaseSimke W Waijer, Taha Sen, Clare Arnott, et al.Pageof 38